GSK
(NYSE) GSK
GSK Financials at a Glance
Market Cap
$108.72B
Revenue (TTM)
$32.67B
Net Income (TTM)
$5.72B
EPS (TTM)
$3.66
P/E Ratio
14.66
Dividend
$1.78
Beta (Volatility)
0.26 (Low)
Dividend
$1.78
Beta (Volatility)
0.26 (Low)
Price
$54.56
Volume
6,752,025
Open
$54.37
Price
$54.56
Volume
6,752,025
Open
$54.37
Previous Close
$54.47
Daily Range
$54.17 - $55.02
52-Week Range
$35.45 - $61.70
Dividend
$1.78
Beta (Volatility)
0.26 (Low)
Price
$54.56
Volume
6,752,025
Open
$54.37
Previous Close
$54.47
Daily Range
$54.17 - $55.02
52-Week Range
$35.45 - $61.70
GSK News
GSK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Emma N. Walmsley
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GSK Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
22%
Net Income Margin
17%
Return on Equity
38%
Return on Capital
18%
Return on Assets
9%
Earnings Yield
6.82%
Dividend Yield
3.26%
Payout Ratio
44.86%
Stock Overview
Market Cap
$108.72B
Shares Outstanding
2.00B
Volume
6.75M
Avg. Volume
5.20M
Financials (TTM)
Gross Profit
$23.18B
Operating Income
$7.01B
EBITDA
$11.62B
Operating Cash Flow
$7.14B
Capital Expenditure
$1.32B
Free Cash Flow
$5.82B
Cash & ST Invst.
$3.40B
Total Debt
$17.69B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.62B
+6.2%
Gross Profit
$6.01B
+8.1%
Gross Margin
69.70%
N/A
Market Cap
$108.72B
N/A
Market Cap/Employee
$1.58M
N/A
Employees
68,629
N/A
Net Income
$636.00M
+53.6%
EBITDA
$1.94B
+73.2%
Quarterly Fundamentals
Net Cash
$14.29B
-7.7%
Accounts Receivable
$7.75B
+29.1%
Inventory
$5.91B
+4.3%
Long Term Debt
$14.68B
+0.3%
Short Term Debt
$3.01B
+28.0%
Return on Assets
9.35%
N/A
Return on Invested Capital
18.05%
N/A
Free Cash Flow
$1.48B
+23.6%
Operating Cash Flow
$2.04B
-12.6%